Risks of Recurrent Cardiovascular Events and Mortality in 1-Year Survivors of Acute Myocardial Infarction Implanted with Newer-Generation Drug-Eluting Stents

Current treatments for acute myocardial infarction (AMI) have dramatically improved clinical outcomes during the first year after AMI. Less is known, however, about the subsequent risks of recurrent cardiovascular events and mortality in patients who survive 1 year after AMI. The purpose of the pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sungmin, Choo, Eun Ho, Choi, Ik Jun, Lee, Kwan Yong, Lee, Su Nam, Hwang, Byung-Hee, Kim, Chan Joon, Park, Mahn-Won, Lee, Jong-Min, Park, Chul Soo, Kim, Hee-Yeol, Yoo, Ki-Dong, Jeon, Doo Soo, Youn, Ho Joong, Chung, Wook Sung, Kim, Min Chul, Jeong, Myung Ho, Yim, Hyeon Woo, Ahn, Youngkeun, Chang, Kiyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396866/
https://www.ncbi.nlm.nih.gov/pubmed/34441938
http://dx.doi.org/10.3390/jcm10163642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396866/
https://www.ncbi.nlm.nih.gov/pubmed/34441938
http://dx.doi.org/10.3390/jcm10163642

Ejemplares similares